Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2014-03-31 Director's Dealing
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - P Ford 2 pages 407.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholdings, including the number of securities held before and after the change, the nature of the change (on-market purchase), and related dates. This matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives. The document is not an announcement of a report, nor does it contain financial statements or management commentary. Therefore, it fits the 'Director's Dealing' category.
2014-03-31 English
Release of Shares from Escrow 1 page 315.5KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Bioxyne Limited to the Australian Securities Exchange Companies Announcements Office regarding the release of shares from escrow. It references specific ASX listing rules and details about share release dates and share counts. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The content is about share capital status and escrow release, which fits best under a capital or financing update category. Given the nature of the announcement about shares being released from escrow and the absence of other report types, the appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on capital structure changes, not a full report or regulatory filing.
2014-03-17 English
Half Yearly Report and Accounts 19 pages 1.9MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D – Half Year Report' and is dated 28 February 2014, covering the half year ended 31 December 2013. It includes detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. It also contains a Directors' Report and an Auditor's Independence Declaration. The presence of comprehensive financial data and analysis for a half-year period clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2014
2014-02-27 English
Completion of the Sale of HI-164 Program 2 pages 259.6KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 24 February 2014 from Bioxyne Limited regarding the completion of the sale of a subsidiary and intellectual property to another company. It details the terms of the sale, including cash, equity, deferred consideration, and royalties. There is no financial report, earnings data, or regulatory filing form referenced. The document is a transactional update about a sale and purchase agreement and related agreements. This fits the category of Capital/Financing Update (CAP), as it relates to company financing activities and asset sales. The document length is short (3078 characters) and contains substantive content about the transaction, not just an announcement of a report or certification. Therefore, the correct classification is CAP with high confidence.
2014-02-24 English
Change of Director's Interest Notice - P Ford 2 pages 725.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including dates, number of shares/options acquired, and nature of transactions. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor a full financial report, but a specific notification of director share transactions.
2014-02-24 English
Change of Director's Interest Notice - P Ford 2 pages 725.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of shares and options held before and after the change, the nature of the transactions, and dates. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial statements, earnings data, or other report types. Therefore, it fits the definition of Director's Dealing (DIRS). The document length is under 5,000 characters and is a direct notice, not an announcement of a report publication or certification. Hence, the classification is DIRS with high confidence.
2014-02-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.